[ad_1]
London / Sydney. In the United States, Canada and the Netherlands, chronic non-cancer pain is the leading cause of cannabis use as a drug. But large-scale scientific studies are rare. A recent long-term Australian study published in the British medical journal The Lancet Public Health (July 2018) showed negative results.
"People who use cannabis have more pain and less self-management of their pain.Nothing indicated that cannabis reduced the intensity of pain or that it had a savings effect on opioids, "writes Gabrielle Campbell of the National Drug and Alcohol Research Center at the University of New South Wales in Sydney, Australia, and her co-authors. </ p> <p> The study was funded by the National Australian Medical Research Center and the Australian Government.
Frequent prescription of opioid depression caused
During the investigation, cannabis use was reported in patients for four years with pain-related cancer without looking at which opiates have been prescribed as pain relievers by their doctors.So, doctors should try to use opioids to relieve pain in these patients only if no n other way is available.
The very frequent prescription of opioids in patients with chronic pain without tumor has resulted in an increase in opioids in the United States since the 1990s. The crisis has led. In 2016, more than 42,000 people died of opioids in the United States – more than ever before. In more than 40 percent of these deaths, there have been, according to health authorities in connection with a prescription opioid. Many addicts in the United States have slipped into opioid addiction via prescription painkillers such as oxycodone. Of course, treatments that would reduce the dosage of opioids otherwise necessary would be desirable
No miracle to be expected
In the Australian study, however, this was not not the case of cannabis. Cannabis use was common, with 295 participants (24%) using cannabis as an badgesic at the end of the four-year follow-up period, with 364 subjects (33%) indicating badgesic use at the beginning of the study , against 732 after four years. (60%) (…) We have found no evidence of a temporal relationship between the use of cannabis and the severity of painful symptoms, pain-induced alterations, a reduction in the prescribed opioid dose, or an increase in the cessation of opioid badgesics. the experts
The National Council Health Committee recently asked Minister Beate Hartinger-Klein (FPÖ) to prepare a report on the therapeutic use of cannabis in medicine by the end of the year. 2018. In the spring, health insurance of German technicians published an expert report written with their support on the subject. "Miracles are obviously not to be expected from cannabis in different indications." In pain medicine and paralysis, the quality of scientific evidence of effectiveness is "at best moderate (…) There is no efficacy for cannabis in indications of depression, psychosis, dementia , glaucoma and intestinal diseases, "wrote the experts.
Source link
